GALECTIN THERAPEUTICS INC's ticker is and the CUSIP is 363225952. A total of 1 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $7,000 | -53.3% | 2,900 | -47.3% | 0.00% | – |
| Q2 2015 | $15,000 | -28.6% | 5,500 | -8.3% | 0.00% | – |
| Q4 2014 | $21,000 | -70.4% | 6,000 | -57.4% | 0.00% | – |
| Q3 2014 | $71,000 | -29.7% | 14,100 | +93.2% | 0.00% | – |
| Q2 2014 | $101,000 | -58.8% | 7,300 | -54.4% | 0.00% | – |
| Q1 2014 | $245,000 | – | 16,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 14,100 | $71,000 | 0.00% |